OPKO Health Inc. Logo

OPKO Health Inc.

Provides clinical diagnostics & develops novel therapies for serious & pediatric diseases.

OPK | TA

Overview

Corporate Details

ISIN(s):
US68375N1037
LEI:
Country:
Israel
Address:
4400 Biscayne Blvd., 33137 Miami
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a diversified and fully-integrated healthcare company operating in the diagnostics and pharmaceuticals sectors. Its diagnostics division features BioReference Laboratories, one of the largest full-service clinical reference laboratories in the U.S. The pharmaceuticals division focuses on discovering, developing, and commercializing novel therapies for serious diseases. Key marketed products include NGENLA™, a next-generation human growth hormone therapy for pediatric patients, and RAYALDEE®. The company's research pipeline is centered on advancing multispecific therapies for conditions like cancer and infectious diseases, supported by strategic partnerships with leading pharmaceutical and scientific organizations such as Pfizer and Merck.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 11:31
M&A Activity
Labcorp completes acquisition of select assets of BioReference.
English 117.0 KB
2025-09-16 11:31
Foreign Filer Report
Labcorp completes acquisition of select assets of BioReference.
English 36.4 KB
2025-08-20 01:46
Director's Dealing
Immediate Report
English 51.4 KB
2025-08-20 01:46
Foreign Filer Report
Immediate Report
English 36.3 KB
2025-08-10 02:28
Director's Dealing
Immediate Report
English 51.5 KB
2025-08-10 02:28
Related Party Transaction
Immediate Report
English 36.3 KB
2025-08-01 01:34
Foreign Filer Report
Report of Periodic or Interim Report
English 36.6 KB
2025-08-01 01:19
Quarterly Report
Immediate Report
English 202.1 KB
2025-08-01 01:19
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-08-01 01:13
Earnings Release
Immediate Report
English 292.7 KB
2025-08-01 01:13
Foreign Filer Report
Immediate Report
English 36.4 KB
2025-07-26 22:17
Report Publication Announcement
Immediate Report
English 162.7 KB
2025-07-26 22:17
Report Publication Announcement
Immediate Report
English 36.4 KB
2025-07-08 17:09
Regulatory News Service
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
English 160.7 KB
2025-07-08 17:09
Foreign Filer Report
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
English 36.4 KB

Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.